Linked Life Data

8925976

Source:http://linkedlifedata.com/resource/pubmed/id/8925976

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1996-11-12
pubmed:abstractText
The most frequent progestins used as contraceptives with or without estrogens and their effects on glucose tolerance tests and insulin secretion is reviewed. Although changes observed were moderate, they became normal after few cycles of contraceptive use. All combined contraceptives (progestin plus ethynyl estradiol) produced some deterioration of glucose in the tolerance tests and increase in insulin secretion, although these changes were within normal accepted levels. The most notable changes were seen with levonorgestrel, mono or thiphasic, and were minimal with desogestrel or gestodene. No changes occurred with pregnane type compounds, like medroxy progesterone acetate, with no estrogens as the most representative of this group. The determinations of insulin secretion are more reliable if peptide C in plasma is determined, as it is released by the pancreas in an equimolar amount with insulin and is not retained by the liver.
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0300-9041
pubmed:author
pubmed:issnType
Print
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
198-200
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
[Oral hormonal contraceptives and carbohydrate metabolism].
pubmed:affiliation
Facultad de Medicina, Universidad Nacional Autónoma de México, Departamento de Ginecología, Hospital A.B.C. México, D.F.
pubmed:publicationType
Journal Article, Comparative Study, English Abstract